JP2005511084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511084A5 JP2005511084A5 JP2003551273A JP2003551273A JP2005511084A5 JP 2005511084 A5 JP2005511084 A5 JP 2005511084A5 JP 2003551273 A JP2003551273 A JP 2003551273A JP 2003551273 A JP2003551273 A JP 2003551273A JP 2005511084 A5 JP2005511084 A5 JP 2005511084A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- cell population
- differentiated
- pps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 42
- 238000000034 method Methods 0.000 claims 5
- 108010022580 Hematopoietic Cell Growth Factors Proteins 0.000 claims 3
- 102000012428 Hematopoietic Cell Growth Factors Human genes 0.000 claims 3
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 3
- 238000003556 assay Methods 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 210000001671 embryonic stem cell Anatomy 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 claims 2
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 claims 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
- 238000011789 NOD SCID mouse Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
- 210000004698 lymphocyte Anatomy 0.000 claims 2
- 210000001616 monocyte Anatomy 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 102100022749 Aminopeptidase N Human genes 0.000 claims 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims 1
- 108010002386 Interleukin-3 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 241000288906 Primates Species 0.000 claims 1
- 210000003651 basophil Anatomy 0.000 claims 1
- 210000002459 blastocyst Anatomy 0.000 claims 1
- 229940112869 bone morphogenetic protein Drugs 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 210000003979 eosinophil Anatomy 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 claims 1
- 210000000267 erythroid cell Anatomy 0.000 claims 1
- 108700014844 flt3 ligand Proteins 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 230000006057 immunotolerant effect Effects 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 210000003593 megakaryocyte Anatomy 0.000 claims 1
- 229960004857 mitomycin Drugs 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 210000003924 normoblast Anatomy 0.000 claims 1
- 238000007747 plating Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33897901P | 2001-12-07 | 2001-12-07 | |
| US60/338,979 | 2001-12-07 | ||
| PCT/US2002/039091 WO2003050251A2 (en) | 2001-12-07 | 2002-12-06 | Hematopoietic cells from human embryonic stem cells |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009265829A Division JP2010075195A (ja) | 2001-12-07 | 2009-11-24 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2013127621A Division JP2013236636A (ja) | 2001-12-07 | 2013-06-18 | ヒト胚性幹細胞に由来する造血細胞 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2005511084A JP2005511084A (ja) | 2005-04-28 |
| JP2005511084A6 JP2005511084A6 (ja) | 2005-08-04 |
| JP2005511084A5 true JP2005511084A5 (https=) | 2005-12-22 |
| JP5364224B2 JP5364224B2 (ja) | 2013-12-11 |
Family
ID=23326944
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003551273A Expired - Fee Related JP5364224B2 (ja) | 2001-12-07 | 2002-12-06 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2009265829A Pending JP2010075195A (ja) | 2001-12-07 | 2009-11-24 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2013127621A Withdrawn JP2013236636A (ja) | 2001-12-07 | 2013-06-18 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2016146156A Pending JP2016187354A (ja) | 2001-12-07 | 2016-07-26 | ヒト胚性幹細胞に由来する造血細胞 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009265829A Pending JP2010075195A (ja) | 2001-12-07 | 2009-11-24 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2013127621A Withdrawn JP2013236636A (ja) | 2001-12-07 | 2013-06-18 | ヒト胚性幹細胞に由来する造血細胞 |
| JP2016146156A Pending JP2016187354A (ja) | 2001-12-07 | 2016-07-26 | ヒト胚性幹細胞に由来する造血細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030153082A1 (https=) |
| EP (2) | EP1463803B1 (https=) |
| JP (4) | JP5364224B2 (https=) |
| KR (3) | KR101457742B1 (https=) |
| CN (2) | CN1630716A (https=) |
| AU (2) | AU2002366603B2 (https=) |
| CA (1) | CA2469483C (https=) |
| GB (2) | GB2412379B (https=) |
| IL (3) | IL162130A0 (https=) |
| WO (1) | WO2003050251A2 (https=) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| GB0210539D0 (en) * | 2002-05-08 | 2002-06-19 | Univ Edinburgh | Control of es cell self renewal and lineage specification, and medium therefor |
| US7285415B2 (en) | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| UA72310C2 (en) * | 2002-09-03 | 2005-02-15 | Oleksandr Leonidovy Kukharchuk | Kukharchuk-radchenko-sirman method for reinstallation of system controlling antigenic homeostasis of the body |
| ES2705683T3 (es) | 2002-12-16 | 2019-03-26 | Technion Res & Dev Foundation | Medio de cultivo de células madre pluripotentes |
| WO2006040615A2 (en) * | 2003-06-11 | 2006-04-20 | Jan Remmereit | Differenciation of stem cells for therapeutic use |
| WO2005049812A1 (en) * | 2003-11-19 | 2005-06-02 | Australian Stem Cell Centre Limited | Methods for producing blood products from pluripotent cells in cell culture |
| US20050221482A1 (en) * | 2004-03-31 | 2005-10-06 | Burt Richard K | Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof |
| JP2008505650A (ja) * | 2004-07-12 | 2008-02-28 | ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ | ヒト細胞を増殖させるための装置及び方法 |
| WO2006017370A2 (en) | 2004-07-13 | 2006-02-16 | Geron Corporation | Medium for growing human embryonic stem cells |
| CA2611809C (en) | 2005-06-22 | 2018-06-19 | Geron Corporation | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
| KR20160116024A (ko) | 2005-06-22 | 2016-10-06 | 아스테리아스 바이오세라퓨틱스, 인크. | 인간 배아 줄기 세포의 현탁 배양 |
| WO2007026353A2 (en) | 2005-08-29 | 2007-03-08 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
| KR102651433B1 (ko) * | 2006-04-14 | 2024-03-25 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 혈관 콜로니 형성 세포 |
| EP2059586B1 (en) | 2006-08-02 | 2016-07-20 | Technion Research & Development Foundation Ltd. | Methods of expanding embryonic stem cells in a suspension culture |
| US8058064B2 (en) * | 2006-10-04 | 2011-11-15 | The University Of Tokyo | Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells |
| US20080108044A1 (en) * | 2006-11-08 | 2008-05-08 | Deepika Rajesh | In vitro differentiation of hematopoietic cells from primate embryonic stem cells |
| US20100291042A1 (en) | 2007-05-03 | 2010-11-18 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
| WO2009104825A1 (en) * | 2008-02-18 | 2009-08-27 | Kaist | Method for inducing the defferentiation of embryonic stem cells into hemangioblast |
| KR101946785B1 (ko) * | 2008-03-27 | 2019-02-12 | 아스테리아스 바이오세라퓨틱스, 인크. | 영장류 다능성 줄기 세포의 조혈계 세포로의 분화 |
| JPWO2009119105A1 (ja) * | 2008-03-28 | 2011-07-21 | 国立大学法人 東京大学 | ＧＰＩｂα＋ＧＰＶ＋ＧＰＶＩ＋血小板のインビトロ調製法 |
| CN101981181B (zh) | 2008-04-01 | 2013-05-29 | 国立大学法人东京大学 | 由iPS细胞制备血小板的方法 |
| EP2712921B1 (en) | 2008-05-06 | 2018-07-11 | Astellas Institute for Regenerative Medicine | Hemangio colony forming cells and non-engrafting hemangio cells |
| JP5748654B2 (ja) | 2008-05-06 | 2015-07-15 | オカタ セラピューティクス， インコーポレイテッド | 多能性幹細胞に由来する除核赤血球細胞を産生するための方法 |
| WO2010031185A1 (en) * | 2008-09-19 | 2010-03-25 | Protox Therapeutics Inc. | Treating cancer stem cells using targeted cargo proteins |
| KR101720961B1 (ko) * | 2009-02-27 | 2017-03-29 | 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 | 다능성 세포의 분화 |
| US8518397B2 (en) * | 2009-08-14 | 2013-08-27 | Case Western Reserve University | Notch induced natural killer cell generation and therapeutic uses |
| EP2490701B9 (en) | 2009-10-19 | 2017-11-15 | Cellular Dynamics International, Inc. | Cardiomyocyte production |
| EP3633025B1 (en) | 2009-11-12 | 2022-09-14 | Technion Research & Development Foundation Ltd. | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
| ES2608937T3 (es) * | 2010-02-22 | 2017-04-17 | Université Pierre Et Marie Curie (Paris 6) | Medio de cultivo celular para el crecimiento y diferenciación de células del linaje hematopoyético |
| CA2802087A1 (en) | 2010-06-15 | 2011-12-22 | Cellular Dynamics International, Inc. | A compendium of ready-built stem cell models for interrogation of biological response |
| WO2012018933A2 (en) | 2010-08-04 | 2012-02-09 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
| CN102080065A (zh) * | 2010-12-09 | 2011-06-01 | 协和干细胞基因工程有限公司 | 一种用于脐带血造血干细胞扩增的培养体系及其应用 |
| US20140329314A1 (en) | 2011-03-29 | 2014-11-06 | Christopher O'Sullivan | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
| CN102732483B (zh) * | 2011-03-31 | 2014-12-03 | 北京大学 | 造血祖细胞的制备方法及其专用培养基 |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| KR102246369B1 (ko) | 2011-11-30 | 2021-04-29 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 중간엽 간질 세포 및 이에 관련된 용도 |
| GB201210857D0 (en) | 2012-06-19 | 2012-08-01 | Cambridge Entpr Ltd | Transcription factor mediated programming towards megakaryocytes |
| US9745551B2 (en) | 2012-07-12 | 2017-08-29 | Imstem Biotechnology, Inc. | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| CA3177929A1 (en) | 2012-12-21 | 2014-06-26 | Astellas Institute For Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| SG11201510177WA (en) | 2013-06-11 | 2016-01-28 | Harvard College | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
| EP3134515B1 (en) | 2014-04-24 | 2019-03-27 | Board of Regents, The University of Texas System | Application of induced pluripotent stem cells to generate adoptive cell therapy products |
| WO2016100909A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF |
| WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
| CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| US10724003B2 (en) * | 2015-01-16 | 2020-07-28 | Agency For Science, Technology And Research | Method of differentiating human pluripotent stem cells into primitive macrophages |
| CN104694471A (zh) * | 2015-03-25 | 2015-06-10 | 奥思达干细胞有限公司 | 体外诱导胚胎干细胞分化为红系细胞的方法 |
| CN104857503A (zh) * | 2015-05-29 | 2015-08-26 | 华东理工大学 | 促进造血损伤修复的药物组合物 |
| KR101756337B1 (ko) | 2015-08-12 | 2017-07-10 | 고려대학교 산학협력단 | Cxcr2 억제를 통한 인간 전분화능 줄기세포의 내배엽 및 중배엽 분화 방법 |
| CN105238758A (zh) * | 2015-09-17 | 2016-01-13 | 中国科学院广州生物医药与健康研究院 | 一种体外获得造血干/祖细胞的方法 |
| MX2018005274A (es) | 2015-10-30 | 2019-09-19 | The Regents Of The Universtiy Of California | Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t. |
| CN110637083A (zh) * | 2017-03-20 | 2019-12-31 | 华盛顿大学 | 细胞及其使用和制备方法 |
| CN110997904B (zh) * | 2017-03-21 | 2024-11-26 | 法国血液机构 | 改进造血移植物的方法 |
| KR20250048146A (ko) | 2017-11-15 | 2025-04-07 | 셈마 테라퓨틱스, 인크. | 섬세포 제조 조성물 및 사용 방법 |
| WO2020033879A1 (en) | 2018-08-10 | 2020-02-13 | Semma Therapeutics, Inc. | Stem cell derived islet differentiation |
| JP7446242B2 (ja) * | 2018-12-20 | 2024-03-08 | 住友化学株式会社 | 胚型赤芽球を含む細胞集団及びその製造方法、細胞培養組成物並びに化合物試験法 |
| JP7558246B2 (ja) * | 2019-07-24 | 2024-09-30 | ミルテニー バイオテック ベー．フェー． ウント コー． カー・ゲー | コロニー形成細胞を同定するためのアッセイ |
| AU2022343749A1 (en) | 2021-09-13 | 2024-03-28 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of committed cardiac progenitor cells |
| KR20250075707A (ko) | 2022-09-30 | 2025-05-28 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | 심장 섬유아세포의 제조 방법 |
| WO2024228384A1 (ja) * | 2023-04-30 | 2024-11-07 | 国立大学法人北海道大学 | 免疫寛容誘導用組成物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE739273A (https=) | 1968-10-16 | 1970-03-02 | ||
| GB2197915B (en) | 1986-11-19 | 1990-11-14 | Rolls Royce Plc | Improvements in or relating to fluid bearings |
| US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
| US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5622853A (en) | 1990-05-01 | 1997-04-22 | Becton Dickinson And Company | T lymphocyte precursor |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5869243A (en) | 1996-03-05 | 1999-02-09 | Rhode Island Hospital | Immortalized hepatocytes |
| EP0932686A2 (en) | 1996-10-01 | 1999-08-04 | Geron Corporation | Telomerase reverse transcriptase |
| CA2277278A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| AU6869198A (en) * | 1997-03-25 | 1998-10-20 | Morphogenesis, Inc. | Universal stem cells |
| US6090622A (en) | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
| AU729377B2 (en) | 1997-10-23 | 2001-02-01 | Asterias Biotherapeutics, Inc. | Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture |
| CA2219869A1 (en) | 1997-10-31 | 1999-04-30 | Hsc Research And Development Limited Partnership | Human cd-34 hematopoietic stem cells |
| AU3881499A (en) * | 1998-09-01 | 2000-03-21 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells with compatible histocompatibility genes |
| US6667176B1 (en) * | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| AU7445800A (en) | 1999-09-27 | 2001-04-30 | Chugai Seiyaku Kabushiki Kaisha | Method of prolonging normal cell life span |
| US6280718B1 (en) * | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
| EP1254211A4 (en) | 2000-01-14 | 2003-07-16 | Bresagen Ltd | PRODUCTION OF CELLS |
| US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
| JP5943533B2 (ja) | 2000-05-17 | 2016-07-06 | アステリアス バイオセラピューティクス インコーポレイテッド | 神経前駆細胞の集団 |
| US20020086005A1 (en) | 2000-11-22 | 2002-07-04 | Choy-Pik Chiu | Tolerizing allografts of pluripotent stem cells |
| US6576464B2 (en) | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
| DE10061334A1 (de) * | 2000-12-04 | 2002-06-13 | Max Delbrueck Centrum | Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes |
| CA2453187A1 (en) * | 2001-07-10 | 2003-01-23 | J & J Research Pty Ltd | Production of transduced hematopoietic progenitor cells |
-
2002
- 2002-12-06 US US10/313,196 patent/US20030153082A1/en not_active Abandoned
- 2002-12-06 CN CNA028270649A patent/CN1630716A/zh active Pending
- 2002-12-06 GB GB0503865A patent/GB2412379B/en not_active Expired - Fee Related
- 2002-12-06 EP EP02804740.5A patent/EP1463803B1/en not_active Expired - Lifetime
- 2002-12-06 KR KR1020107024253A patent/KR101457742B1/ko not_active Expired - Fee Related
- 2002-12-06 KR KR10-2004-7008756A patent/KR20040081741A/ko not_active Ceased
- 2002-12-06 CA CA2469483A patent/CA2469483C/en not_active Expired - Fee Related
- 2002-12-06 CN CN200910174800.4A patent/CN102008503B/zh not_active Expired - Fee Related
- 2002-12-06 JP JP2003551273A patent/JP5364224B2/ja not_active Expired - Fee Related
- 2002-12-06 EP EP10175120A patent/EP2292734A1/en not_active Withdrawn
- 2002-12-06 AU AU2002366603A patent/AU2002366603B2/en not_active Ceased
- 2002-12-06 IL IL16213002A patent/IL162130A0/xx unknown
- 2002-12-06 WO PCT/US2002/039091 patent/WO2003050251A2/en not_active Ceased
- 2002-12-06 GB GB0414957A patent/GB2399572B/en not_active Expired - Fee Related
- 2002-12-06 KR KR1020137015273A patent/KR20130072272A/ko not_active Ceased
-
2004
- 2004-05-23 IL IL162130A patent/IL162130A/en not_active IP Right Cessation
-
2008
- 2008-11-10 AU AU2008243182A patent/AU2008243182A1/en not_active Abandoned
-
2009
- 2009-09-06 IL IL200768A patent/IL200768A/en active IP Right Grant
- 2009-11-24 JP JP2009265829A patent/JP2010075195A/ja active Pending
-
2013
- 2013-06-18 JP JP2013127621A patent/JP2013236636A/ja not_active Withdrawn
-
2016
- 2016-07-26 JP JP2016146156A patent/JP2016187354A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511084A5 (https=) | ||
| Sánchez et al. | Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo | |
| Sitnicka et al. | Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool | |
| Hirayama et al. | The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors | |
| Rebel et al. | Amplification of Sca-1+ Lin-WGA+ cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential | |
| Ueda et al. | IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia | |
| Broxmeyer et al. | Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. | |
| EP0937461B1 (en) | Use of proteins from the mk family as hematopoietic factor | |
| Kitamura et al. | Regulation of mast cell differentiation | |
| US20120082688A1 (en) | In Vitro Generation of Myeloid Derived Suppressor Cells | |
| JP2018023343A (ja) | 細胞培養用培地、及び細胞培養方法 | |
| Yamaguchi et al. | Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum | |
| Bradley et al. | Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness | |
| Roodman et al. | Tumor necrosis factor α and the anemia of chronic disease: Effects of chronic exposure to TNF on erythropoiesis in vivo | |
| Piguet et al. | Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells | |
| Ende et al. | Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents | |
| Hidaka et al. | Mirimostim (macrophage colony‐stimulating factor; M‐CSF) improves chemotherapy‐induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function | |
| Rottem et al. | Early development of mast cells | |
| Moore | The future of cytokine combination therapy | |
| Davis et al. | Conditioned medium from primary porcine endothelial cells alone promotes the growth of primitive human haematopoietic progenitor cells with a high replating potential: evidence for a novel early haematopoietic activity | |
| Andréasson et al. | Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia | |
| Law et al. | Mobilization of peripheral blood progenitor cells for human immunodeficiency virus–infected individuals | |
| Heyworth et al. | 14 Growth factors and the regulation of haemopoietic stem cells | |
| Ma et al. | Cytokine requirement for the development of T‐lymphoid lineage potential in clonal lymphohaematopoietic progenitors in vitro | |
| CN1310672C (zh) | 作为造血刺激物的成骨生长寡肽 |